Evidence map›Paper›PMID 35273753›Full record

ArticleSleep science (Sao Paulo, Brazil)

Validation of the Colombian version of the Karolinska sleepiness scale.

María Camila Laverde-López, Franklin Escobar-Córdoba, Javier Eslava-Schmalbach

Abstract read
In one paragraph

Article in Sleep science (Sao Paulo, Brazil). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Validation of the Karolinska Sleepiness Scale in Korean.Journal of clinical neurology (Seoul, Korea) · 2024
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

María Camila Laverde-LópezUniversidad Nacional de Colombia, Faculty of Medicine, Department of Internal Medicine, Aerospace Medicine Specialty - Bogotá - Bogotá D.C. - Colombia.
Franklin Escobar-CórdobaUniversidad Nacional de Colombia, Faculty of Medicine, Psychiatry Department - Bogotá - Bogotá D.C. - Colombia.
Javier Eslava-SchmalbachUniversidad Nacional de Colombia, Hospital Universitario Nacional de Colombia - Bogotá - Bogotá D.C. - Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Currently, daytime sleepiness is a prevalent condition worldwide. Locally validated instruments for measuring sleepiness are required. The objective of this study was to validate a version of the Karolinska sleepiness scale that was translated into the Spanish spoken in Colombia. Methods: Individuals who attended a sleep laboratory for a polysomnography study and people in the general population were included. The validation process was performed in 6 phases: translation and back translation of the original version of the scale (English), face validity (n=13), pilot test (n=20), criteria validity (n=139) by means of polysomnography and the Epworth sleepiness scale, reproducibility (n=34), and sensitivity to change (n=40). Results: Regarding its discriminant validity, the Colombian version of the Karolinska sleepiness scale is correlated with the Epworth sleepiness scale, provided that a Mann-Whitney z=2661 (p=0.0078) was obtained. The scale has an acceptable reproducibility, Spearman Rho=0.55 (p=0.0002), and sensitivity to change, as shown through a two-tailed t test (p=0.0000). Conclusions: The Karolinska Sleepiness Scale was successfully adapted to the Spanish variation spoken in Colombian and to the conditions of adult Colombians; thus, it constitutes a valid, reliable, and easy to use instrument for the assessment of patients with hypersomnia.

Indexed as

ColombiaDisorders of Excessive SomnolenceSleep Wake Disorders (MeSH)Validation Studies

Identifiers

PMID35273753
PMCPMC8889981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.